V028-2826 Screening compound: 1-[1-benzoyl-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine

V028-2826 Screening compound: 1-[1-benzoyl-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine
V028-2826 Screening compound: 1-[1-benzoyl-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-2826
1-[1-benzoyl-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-2826

Molecular Formula

C32H37N3O6 (C32 H37 N3 O6)

Compound Name

1-[1-benzoyl-4-(3,4,5-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine

IUPAC name

1-[1-benzoyl-4-(345-trimethoxyphenyl)pyrrolidine-3-carbonyl]-4-(2-methoxyphenyl)piperazine

SMILES

COc(cccc1)c1N(CC1)CCN1C(C(CN(C1)C(c2ccccc2)=O)C1c(cc1OC)cc(OC)c1OC)=O

InChI

InChI=1S/C32H37N3O6/c1-38-27-13-9-8-12-26(27)33-14-16-34(17-15-33)32(37)25-21-35(31(36)22-10-6-5-7-11-22)20-24(25)23-18-28(39-2)30(41-4)29(19-23)40-3/h5-13,18-19,24-25H,14-17,20-21H2,1-4H3

InChI Key

NUPQTKVJRRUYST-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14261135

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

559.66

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.557

Distribution Coefficient, logD

3.556

Water Solubility, LogSw

-3.81

Polar Surface Area

67.064

Acid Dissociation Constant (pKa)

21.09

Base Dissociation Constant (pKb)

4.25

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

37.50

V028-2826 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with V028-2826 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-2826?
Check Price and Availability of V028-2826, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-2826 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-2826
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-2826
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-2826 available by request